TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.

被引:0
作者
Yoneten, K. Karaosmanoglu [1 ]
Gunes, A. [2 ]
Kasap, M. [3 ]
Utkan, N. Z. [4 ]
Akpinar, G. [3 ]
Gurel, B. [5 ]
Guler, S. A. [4 ]
机构
[1] Kocaeli Univ, Fac Technol, Dept Biomed Engn, Kocaeli, Turkey
[2] Derince Training & Res Hosp, Dept Gen Surg, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Med, Dept Med Biol, Kocaeli, Turkey
[4] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkey
[5] Kocaeli Univ, Fac Med, Dept Med Pathol, Kocaeli, Turkey
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P2204
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The challenges of modeling hormone receptor-positive breast cancer in mice
    Ozdemir, Berna C.
    Sflomos, George
    Brisken, Cathrin
    [J]. ENDOCRINE-RELATED CANCER, 2018, 25 (05) : R319 - R330
  • [32] Understanding Resistance to Tamoxifen in Hormone Receptor-Positive Breast Cancer
    Higgins, Michaela J.
    Stearns, Vered
    [J]. CLINICAL CHEMISTRY, 2009, 55 (08) : 1453 - 1455
  • [33] Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer
    Yi, Zongbi
    Ma, Fei
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (04) : 321 - 326
  • [34] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    [J]. FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [35] Overcoming endocrine resistance in hormone receptor-positive breast cancer
    AlFakeeh, A.
    Brezden-Masley, C.
    [J]. CURRENT ONCOLOGY, 2018, 25 : S18 - S27
  • [36] Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer.
    Cuzick, J
    Howell, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 43S - 43S
  • [37] Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Moore, Halle C. F.
    Maiti, Baidehi
    Rybicki, Lisa A.
    Booth, Christine
    Abraham, Jame
    Budd, G. Thomas
    Andresen, Steven Ware
    Downs-Kelly, Erinn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    [J]. LANCET ONCOLOGY, 2019, 20 (03) : 312 - 313
  • [39] Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
    Freelander, Allegra
    Brown, Lauren J.
    Parker, Andrew
    Segara, Davendra
    Portman, Neil
    Lau, Brandon
    Lim, Elgene
    [J]. GENES, 2021, 12 (02) : 1 - 24
  • [40] Metastatic, hormone receptor-positive breast cancer-the agony of choice
    van Mackelenbergh, Marion T.
    Friedrich, Michael
    Maass, Nicolai
    [J]. GYNAKOLOGIE, 2025,